Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 23,833 | 22,192 | 18,232 | 16,315 | 9,133 |
| Gross Profit | 23,833 | 22,192 | 18,232 | 16,315 | 9,133 |
| Operating Expenses | 36,664 | 26,149 | 21,124 | 67,653 | 24,086 |
| Operating Income | -12,831 | -3,957 | -2,892 | -51,338 | -14,953 |
| Interest Expense | 208 | 232 | 250 | 272 | 275 |
| Other Income | 1,530 | 3,155 | 4,864 | 4,003 | 2,537 |
| Pre-tax Income | -11,509 | -1,034 | 1,722 | -47,607 | -12,691 |
| Income Tax | 1,251 | 205 | 60 | 5,185 | N/A |
| Net Income Continuous | -12,760 | -1,239 | 1,662 | -52,792 | -12,691 |
| Net Income | $-12,760 | $-1,239 | $1,662 | $-52,792 | $-12,691 |
| EPS Basic Total Ops | -0.31 | -0.03 | 0.06 | -1.35 | -0.34 |
| EPS Basic Continuous Ops | -0.31 | -0.03 | 0.06 | -1.35 | -0.34 |
| EPS Diluted Total Ops | -0.31 | -0.03 | 0.06 | -1.35 | -0.34 |
| EPS Diluted Continuous Ops | -0.31 | -0.03 | 0.06 | -1.35 | -0.34 |
| EBITDA(a) | $-11,485 | $-3,006 | $-1,990 | $-50,290 | $-14,016 |